Liz Allen Joins F1000 as Director of Strategic Initiatives
F1000, a provider of services to biomedical researchers to support the discovery, writing and publication of new scientific findings, has strengthened its senior leadership team with the appointment of Liz Allen as Director of Strategic Initiatives. Liz was formerly Head of Evaluation at the Wellcome Trust, one of the world’s largest biomedical research charities.
Rebecca Lawrence, managing director of F1000, said: “Liz has a strong background and expertise that will help us in building upon our commitment to open science publishing and our ongoing discussions with major research funders around the world. We share a vision around changing not only the way new research findings are published, but also how this can impact how researchers are assessed and evaluated for grants, and for career development and tenure decisions. We are delighted that she is joining the senior management team at F1000 to help us towards this ambitious goal.”
Liz Allen said: “It is an exciting time for science; F1000 are at the fore of open science and their tools and platforms can speed up the way research is made available, shared, used and re-used, to bring efficiencies to all aspects of the research ecosystem.
“It is important that all stakeholders in research – researchers, funding agencies, publishers, the public – work together to embrace the opportunities presented by technology and to foster an environment for expediting the discovery and development of innovation in life sciences and healthcare.”
During 2010-2015 Liz was also Board Director of ORCID (Open Researcher and Contributor ID), and is currently a Co-Chair of Project CRediT (Contributor Roles Taxonomy - http://www.casrai.org/CRediT), which aims to bring greater granularity and transparency to contributions for scholarly outputs. Liz was recently appointed a Visiting Senior Research Fellow in the Policy Institute at King's College London.
F1000 is a suite of tools overseen by a dedicated community of more than 11,000 experts in the life sciences. This community, and the thousands of researchers who publish on F1000Research, are challenging traditional closed door review and lengthy publishing timeframes that can bottleneck research, by facilitating open and communicative dissemination of research in real time.
For more information:
Andrew Baud, Tala (on behalf of F1000), +44 (0) 20 3397 3383 or +44 (0) 7775 715775
Notes to editors
F1000 was founded by science publishing entrepreneur Vitek Tracz, a passionate advocate of open access publishing and open science. F1000 is a community of more than 11,000 biomedical experts who help scientists to discover, discuss and publish research. F1000 offers the following services:
F1000Research - an open science publishing platform for life scientists that offers immediate publication and transparent peer review, avoiding editorial bias and ensuring the inclusion of all source data.
F1000Prime - a service which identifies and recommends important articles in biology and medical research publications.
F1000Workspace - a new research collaboration, reference management and authoring platform for scientists.
For more information go to www.f1000.com
0203 397 3383